Neuraminidase antibodies and H5N1: geographic-dependent influenza epidemiology could determine cross-protection against emerging strains.
Bermejo-Martin
Jesus F
JF
Kelvin
David J
DJ
Guan
Yi
Y
Chen
Honglin
H
Perez-Breña
Pilar
P
Casas
Inmaculada
I
Arranz
Eduardo
E
de Lejarazu
Raul O
RO
D000818:Animals; D000914:Antibodies, Viral / Q000276:immunology*; D004196:Disease Outbreaks / Q000517:prevention & control; D006801:Humans; D053124:Influenza A Virus, H5N1 Subtype / Q000276:immunology*; D007252:Influenza Vaccines / Q000276:immunology / Q000627:therapeutic use; D007251:Influenza, Human / Q000453:epidemiology / Q000276:immunology* / Q000517:prevention & control; D051379:Mice; D009439:Neuraminidase / Q000276:immunology*; D009976:Orthomyxoviridae Infections / Q000453:epidemiology / Q000276:immunology* / Q000517:prevention & control
D000914:Antibodies, Viral; D007252:Influenza Vaccines; D009439:Neuraminidase